Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Market Cap
Union Korea Pharm has a market cap or net worth of 19.7 billion as of January 23, 2026. Its market cap has decreased by -45.97% in one year.
Market Cap
19.70B
Enterprise Value
51.10B
Revenue
33.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,725.00
Market Cap Chart
Since July 26, 2018, Union Korea Pharm's market cap has decreased from 112.03B to 19.70B, a decrease of -82.41%. That is a compound annual growth rate of -24.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 19.70B | -44.88% |
| Dec 28, 2023 | 35.74B | -30.77% |
| Dec 29, 2022 | 51.63B | -33.98% |
| Dec 30, 2021 | 78.19B | -46.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 34.34B |
| ChoA Pharmaceutical Co., LTD. | 27.91B |
| Daesung Microbiological Labs. | 26.83B |
| Pharmsville | 26.43B |
| BL Pharmtech | 25.91B |
| Hurum | 25.87B |
| BIFIDO | 24.70B |
| WooGene B&G | 22.99B |